EphA7 Antibodies

Santa Cruz Biotechnology provides a broad selection of EphA7 monoclonal antibodies for research focused on understanding EphA7 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA7 is a member of the Eph receptor family, which plays a vital role in cell signaling and communication during developmental processes. EphA7 regulates cell adhesion, migration, and positioning, making it essential for proper neuronal development and function. Research has shown that EphA7 expression changes can influence various diseases, including cancer and neurological disorders. Understanding EphA7's molecular mechanisms and signaling pathways can provide valuable insights into potential therapeutic strategies. Investigating EphA7's role in cellular processes requires reliable detection methods and careful experimental design. Current research continues to uncover new functions and regulatory mechanisms of EphA7 in both normal development and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EphA7's role in health and disease progression.